Gestational trophoblastic neoplasia—pathogenesis and potential therapeutic targets

This publication has 58 references indexed in Scilit:

• Application of Human Leukocyte Antigen–G Expression in the Diagnosis of Human Cancer
  Human Immunology, 2007
• Evaluation of deletions in 7q11.2 and 8p12–p21 as prognostic indicators of tumour development following molar pregnancy
  Gynecologic Oncology, 2006
• Gestational Trophoblastic Disease
  Obstetrics & Gynecology, 2006
• Future Directions in the Treatment of Hormone-Sensitive Advanced Breast Cancer: The RAD001 (Everolimus)-Letrozole Clinical Program
  Seminars in Oncology, 2006
• Cancer therapeutics: Targeting the dark side of Myc
  European Journal of Cancer, 2005
• Inactivation of Myc in Murine Two-Hit B lymphomas Causes Dormancy with Elevated Levels of Interleukin 10 Receptor and CD20: Implications for Adjuvant Therapies
  Cancer Research, 2005
• Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation
  Cancer Cell, 2005
• Oncogene addictionSometimes a temporary slavery
  Cancer Cell, 2004
• NECC1, a candidate choriocarcinoma suppressor gene that encodes a homeodomain consensus motif☆☆Sequence data from this article have been deposited with the DDBJ/EMBL/GenBank Data Libraries under Accession No. AB059410.
  Genomics, 2003
• Malignant trophoblastic neoplasms with different modes of origin
  Cancer Genetics and Cytogenetics, 1995